SCHEMBL8446038

SCHEMBL8446038

CCSc1nnc(C)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104190 0.85 ALDH1A1 (0.70)
SCHEMBL13240158 0.83 GAA (0.59)
SCHEMBL12232725 0.82 GAA (0.53)
SCHEMBL8445026 0.79
SCHEMBL8443575 0.79
SCHEMBL425172 0.79 ALDH1A1 (0.56)
SCHEMBL10977302 0.77 GAA (0.53)
SCHEMBL8523619 0.77 ALDH1A1 (0.64)
SCHEMBL4822631 0.76 ALDH1A1 (0.59)
SCHEMBL3280546 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018114596-A1 SUBSTITUTED HETEROARYL PYRROLONES AND SALTS THEREOF AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-06-28 WO disclosed
US-20160244435-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-25 US disclosed
US-RE45686-E1 Disperse dyes, their preparation and their use DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2015-09-29 US disclosed
US-RE45686-E1 Disperse dyes, their preparation and their use DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2015-09-29 US disclosed
US-20150111853-A1 CEPHALOSPORIN COMPOSITIONS AND METHODS OF MANUFACTURE MERCK SHARP & DOHME CORP. 2015-04-23 US disclosed
US-9006421-B2 Cephalosporin compositions and methods of manufacture CUBIST PHARMACEUTICALS, INC. (US) 2015-04-14 US disclosed
WO-2014205414-A1 EXPANDED THERAPEUTIC POTENTIAL IN NITROHETEROARYL ANTIMICROBIALS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-12-24 WO disclosed
US-20140274958-A1 CEPHALOSPORIN COMPOSITIONS AND METHODS OF MANUFACTURE MERCK SHARP & DOHME LLC 2014-09-18 US disclosed
US-20140274999-A1 CEPHALOSPORIN COMPOSITIONS AND METHODS OF MANUFACTURE MERCK SHARP & DOHME CORP. 2014-09-18 US disclosed
US-8383855-B2 Histone deacetylase inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-02-26 US disclosed
US-20080227785-A1 2,4,6-TRIAMINO-1,3,5-TRIAZINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2008-09-18 US disclosed
US-7375222-B2 2,4,6-Triamino-1,3,5-triazine derivative ASTELLAS PHARMA INC. (JP) 2008-05-20 US disclosed
US-7375222-B2 2,4,6-Triamino-1,3,5-triazine derivative ASTELLAS PHARMA INC. (JP) 2008-05-20 US disclosed
WO-2008049758-A2 DISPERSE DYES, THEIR PREPARATION AND THEIR USE DYSTAR TEXTILFARBEN GMBH & CO DEUTSCHLAND KG (DE) 2008-05-02 WO disclosed
US-7244853-B2 Dioxanes and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-07-17 US disclosed
US-20070154948-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-07-05 US disclosed
US-20070154948-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-07-05 US disclosed
US-20070134729-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-06-14 US disclosed
US-20070134729-A1 Novel antibacterial agents THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC 2007-06-14 US disclosed
US-20040072849-A1 Dioxanes and uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-15 US disclosed